Back to Search Start Over

Lexiva oral suspension

Source :
MPR Monthly Prescribing Reference. August, 2007, Vol. 23 Issue 8, pA-12, 1 p.
Publication Year :
2007

Abstract

An oral suspension formulation of GlaxoSmithKline's protease inhibitor Lexiva (fosamprenavir calcium) has been made available for the treatment of patients 2-18 years of age infected with HIV. The 50mg/mL strength [...]

Subjects

Subjects :
GSK PLC -- Product introduction
Antiviral agents -- Product introduction
Fosamprenavir -- Product introduction
Pharmaceutical industry -- Product introduction
Health
Lexiva (Medication) -- Product introduction

Details

Language :
English
ISSN :
08830266
Volume :
23
Issue :
8
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.168162333

Tools

Authors Abstract Subjects Details